Diabetes
-
Dr. Reddy’s Laboratories Ltd. launches new diabetes drug combination in the United States
INDIA – Dr. Reddy’s Laboratories Limited has introduced a new combination product for the treatment of type 2 diabetes in the United States. In a…
-
Novo Nordisk ramps up projections for obesity and diabetes drugs amidst cardiovascular breakthrough
DENMARK — Novo Nordisk, a pioneering force in diabetes and obesity treatments, is boldly elevating its forecasts following groundbreaking results showcasing the cardiovascular benefits of…
-
Eli Lilly’s annual projections skyrocket amid surging demand for diabetes drug Mounjaro, propelling stock to record 18% surge
USA — Eli Lilly has experienced a big jump in its yearly predictions, driven by the growing demand for its new diabetes medication, Mounjaro. The…
-
Wegovy’s heart benefits shine in Novo Nordisk trial, reducing risk of problems
DENMARK —Novo Nordisk has released groundbreaking data from a major trial that showcases Wegovy’s remarkable ability to reduce the risk of “adverse cardiovascular events” by…
-
Glenmark’s generic oral diabetes medication receives full FDA approval
INDIA – Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration (U.S. FDA) for its generic oral diabetes…
-
Eli Lilly’s Mounjaro proves its weight-loss prowess in new studies, setting the stage for potential FDA approval
USA — Eli Lilly’s diabetes drug, Mounjaro, has been making waves in the medical world with its remarkable potential to help overweight and obese individuals…
-
Eli Lilly’s Mounjaro faces ongoing shortages amidst soaring popularity
USA —Eli Lilly’s diabetes medication, Mounjaro has been surging in popularity, particularly for its potential as a weight loss medication, akin to Novo Nordisk’s acclaimed…
-
US FDA approves Lantidra, a cellular therapy revolutionizing type 1 diabetes treatment
USA — The US Food and Drug Administration (FDA) has made a groundbreaking announcement, granting approval to Lantidra, a pioneering cellular therapy for type 1…
-
Eli Lilly to expand cell therapy portfolio with acquisition of Sigilon Therapeutics
USA —In a significant move to bolster its cell therapy portfolio, Eli Lilly has unveiled its plans to acquire Sigilon Therapeutics, a prominent cell therapy…
-
Sernova’s Cell Pouch System shows promise in advancing diabetes treatment
CANADA — Sernova Corp., a clinical-stage company specializing in cell therapeutics, has recently released updated interim data from its ongoing Phase 1/2 clinical trial of…